Growth Metrics

Biofrontera (BFRI) Change in Receivables (2020 - 2025)

Biofrontera has reported Change in Receivables over the past 6 years, most recently at $4.3 million for Q4 2025.

  • For Q4 2025, Change in Receivables rose 768.29% year-over-year to $4.3 million; the TTM value through Dec 2025 reached $1.9 million, up 505.4%, while the annual FY2025 figure was $1.9 million, 505.4% up from the prior year.
  • Change in Receivables for Q4 2025 was $4.3 million at Biofrontera, up from -$947000.0 in the prior quarter.
  • Over five years, Change in Receivables peaked at $4.3 million in Q4 2025 and troughed at -$3.1 million in Q2 2022.
  • A 5-year average of $222000.0 and a median of $149500.0 in 2021 define the central range for Change in Receivables.
  • Biggest five-year swings in Change in Receivables: plummeted 30900.0% in 2022 and later soared 768.29% in 2025.
  • Year by year, Change in Receivables stood at $1.8 million in 2021, then rose by 19.7% to $2.2 million in 2022, then tumbled by 38.93% to $1.3 million in 2023, then plummeted by 63.06% to $492000.0 in 2024, then skyrocketed by 768.29% to $4.3 million in 2025.
  • Business Quant data shows Change in Receivables for BFRI at $4.3 million in Q4 2025, -$947000.0 in Q3 2025, and -$88000.0 in Q2 2025.